C4 Therapeutics

CCCC Micro Cap

Healthcare · Biotechnology

Aktualisiert: Apr 5, 2026, 17:43 UTC

$2.82

+4.44% heute

52W: $1.08 – $3.82

52W Low: $1.08 Position: 63.4% 52W High: $3.82

🔗 Broker vergleichen

Kennzahlen

P/E Ratio

—

Kurs/Gewinn-Verhältnis

Forward P/E

—

Erwartetes KGV

P/S Ratio

7.65x

Kurs/Umsatz-Verhältnis

EV/EBITDA

—

Unternehmenswert/EBITDA

Dividendenrendite

—

Jährl. Dividendenrendite

Market Cap

$275.2M

Marktkapitalisierung

Umsatzwachstum

112.8%

YoY Umsatzwachstum

Gewinnmarge

-292.08%

Nettomarge

ROE

-44.44%

Eigenkapitalrendite

Beta

2.86

Marktsensitivität

Short Interest

14.66%

% der Aktien leerverkauft

Ø Volumen

2,120,514

Durchschn. Tagesvolumen

Bewertungs-Analyse

Signal

N/A

vs. S&P 500 Ø KGV (24.7x)

Analysten-Konsens

Starker Kauf

7 Analysten

Ø Kursziel

$11.57

+310.33% Upside

Kursziel Spanne

$6.00 – $30.00

Über das Unternehmen

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins. Its lead product candidate is Cemsidomide, an orally bioavailable monodac targeting IKZF1 and IKZF3, or IKZF1/3 to address a need across multiple lines of therapy in multiple myeloma, which has competed its phase 1. The company is also developing oncology product candidate, CFT8919, an orally bioavailable, allosteric, mutant-selective bidac degrader of epidermal growth factor receptor, with an L858R mutation in non-small cell lung cancer; and new degraders focused on inflammation, neuroinflammation, and neurodegeneration. It has strategic collaborations F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., Betta Pharmaceuticals Co. Ltd., and Merck KGA

Sektor: Healthcare Branche: Biotechnology Land: United States Mitarbeiter: 104 Börse: NMS

Trading-Daten

50-Day MA: $2.42

200-Day MA: $2.34

Volumen: 2,125,717

Ø Volumen: 2,120,514

Short Ratio: 4.22

Kurs/Buchwert: 1.06x

Verschuldung/EK: 23.38x

Free Cash Flow: $-54,302,624

Wo kann ich C4 Therapeutics kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.

Broker vergleichen →